BeiGene

BeiGene is a life sciences biotechnology company.

BeiGene, founded in October, 2010 and headquartered in Beijing, is an anti-tumor drug developer. The founder is Wu Xiaobin. Listed on the HKEX on August 8, 2018, the company's major shareholders are Beigene, Ltd.. Rivals that have direct and indirect competition with BeiGene include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Specialty Pharma

Founded

Oct 28, 2010

HQ location

Beijing, China

Legal name

BeiGene, Ltd.

Employees

501-1000

See more